XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Shareholders' Equity
9 Months Ended
Sep. 30, 2018
Stockholders' Equity Note [Abstract]  
Shareholders' Equity [Text Block] Shareholders’ Equity
The following tables provide the amounts related to each component of OCI:
 
Three Months Ended September 30,
2018
 
2017
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
(in millions)
Net unrealized securities gains (losses):
 
 
 
 
 
 
 
 
 
 
 
Net unrealized securities gains (losses) arising during the period (1)
$
(106
)
 
$
25

 
$
(81
)
 
$
60

 
$
(22
)
 
$
38

Reclassification of net securities (gains) losses included in net income (2)
(4
)
 
1

 
(3
)
 
(4
)
 
1

 
(3
)
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables
28

 
(6
)
 
22

 
(61
)
 
22

 
(39
)
Net unrealized securities gains (losses)
(82
)
 
20

 
(62
)
 
(5
)
 
1

 
(4
)
 
 
 
 
 
 
 
 
 
 
 
 
Net unrealized derivatives gains (losses):
 
 
 
 
 
 
 
 
 
 
 
Reclassification of net derivative (gains) losses included in net income (3)

 

 

 
1

 

 
1

Net unrealized derivatives gains (losses)

 

 

 
1

 

 
1

 
 
 
 
 
 
 
 
 
 
 
 
Defined benefit plans:
 
 
 
 
 
 
 
 
 
 
 
Net gain (loss) arising during the period

 

 

 

 

 

Defined benefit plans

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation
(5
)
 
2

 
(3
)
 
25

 
(9
)
 
16

Other

 

 

 

 

 

Total other comprehensive income (loss)
$
(87
)
 
$
22

 
$
(65
)
 
$
21

 
$
(8
)
 
$
13


 
Nine Months Ended September 30,
2018
 
2017
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
(in millions)
Net unrealized securities gains (losses):
 
 
 
 
 
 
 
 
 
 
 
Net unrealized securities gains (losses) arising during the period (1)
$
(924
)
 
$
207

 
$
(717
)
 
$
304

 
$
(107
)
 
$
197

Reclassification of net securities (gains) losses included in net income (2)
(14
)
 
3

 
(11
)
 
(43
)
 
15

 
(28
)
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables
347

 
(73
)
 
274

 
(168
)
 
59

 
(109
)
Net unrealized securities gains (losses)
(591
)
 
137

 
(454
)
 
93

 
(33
)
 
60

 
 
 
 
 
 
 
 
 
 
 
 
Net unrealized derivatives gains (losses):
 
 
 
 
 
 
 
 
 
 
 
Reclassification of net derivative (gains) losses included in net income (4)

 

 

 
3

 
(1
)
 
2

Net unrealized derivatives gains (losses)

 

 

 
3

 
(1
)
 
2

 
 
 
 
 
 
 
 
 
 
 
 
Defined benefit plans:
 
 
 
 
 
 
 
 
 
 
 
Net gain (loss) arising during the period

 

 

 
7

 
(2
)
 
5

Defined benefit plans

 

 

 
7

 
(2
)
 
5

 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation
(21
)
 
3

 
(18
)
 
71

 
(25
)
 
46

Other

 

 

 
(1
)
 

 
(1
)
Total other comprehensive income (loss)
$
(612
)
 
$
140

 
$
(472
)
 
$
173

 
$
(61
)
 
$
112


(1) Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income (loss) during the period.
(2) Pretax amounts are recorded in net investment income.
(3) Includes nil pretax gain reclassified to interest and debt expense for both the three months ended September 30, 2018 and 2017, and nil and $1 million pretax loss reclassified to net investment income for the three months ended September 30, 2018 and 2017, respectively.
(4) Includes a $1 million pretax gain reclassified to interest and debt expense for both the nine months ended September 30, 2018 and 2017, and a $1 million and $3 million pretax loss reclassified to net investment income for the nine months ended September 30, 2018 and 2017, respectively.
Other comprehensive income (loss) related to net unrealized securities gains (losses) includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit other-than-temporary impairment losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.
The following tables present the changes in the balances of each component of AOCI, net of tax:
 
Net Unrealized Securities Gains (Losses)
 
Net Unrealized Derivatives Gains (Losses)
 
Defined
Benefit Plans
 
Foreign Currency Translation
 
Other
 
Total
(in millions)
Balance, July 1, 2018
$
93

 
$
8

 
$
(97
)
 
$
(182
)
 
$
(1
)
 
$
(179
)
OCI before reclassifications
(59
)
 

 

 
(3
)
 

 
(62
)
Amounts reclassified from AOCI
(3
)
 

 

 

 

 
(3
)
Total OCI
(62
)
 

 

 
(3
)
 

 
(65
)
Balance, September 30, 2018
$
31

(1) 
$
8

 
$
(97
)
 
$
(185
)
 
$
(1
)
 
$
(244
)
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2018
$
486

 
$
8

 
$
(97
)
 
$
(167
)
 
$
(1
)
 
$
229

Cumulative effect of change in accounting policies
(1
)
 

 

 

 

 
(1
)
OCI before reclassifications
(443
)
 

 

 
(18
)
 

 
(461
)
Amounts reclassified from AOCI
(11
)
 

 

 

 

 
(11
)
Total OCI
(454
)
 

 

 
(18
)
 

 
(472
)
Balance, September 30, 2018
$
31

(1) 
$
8

 
$
(97
)
 
$
(185
)
 
$
(1
)
 
$
(244
)
 
Net Unrealized Securities Gains (Losses)
 
Net Unrealized Derivatives Gains (Losses)
 
Defined
Benefit Plans
 
Foreign Currency Translation
 
Other
 
Total
(in millions)
Balance at July 1, 2017
$
543

 
$
6

 
$
(120
)
 
$
(129
)
 
$
(1
)
 
$
299

OCI before reclassifications
(1
)
 

 

 
16

 

 
15

Amounts reclassified from AOCI
(3
)
 
1

 

 

 

 
(2
)
Total OCI
(4
)
 
1

 

 
16

 

 
13

Balance, September 30, 2017
$
539

(1) 
$
7

 
$
(120
)
 
$
(113
)
 
$
(1
)
 
$
312

 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2017
$
479

 
$
5

 
$
(125
)
 
$
(159
)
 
$

 
$
200

OCI before reclassifications
88

 

 

 
46

 
(1
)
 
133

Amounts reclassified from AOCI
(28
)
 
2

 
5

 

 

 
(21
)
Total OCI
60

 
2

 
5

 
46

 
(1
)
 
112

Balance, September 30, 2017
$
539

(1) 
$
7

 
$
(120
)
 
$
(113
)
 
$
(1
)
 
$
312

(1) Includes $1 million and $8 million of noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities as of September 30, 2018 and September 30, 2017, respectively.
For the nine months ended September 30, 2018 and 2017, the Company repurchased a total of 7.7 million shares and 8.0 million shares, respectively, of its common stock for an aggregate cost of $1.1 billion and $1.0 billion, respectively. In April 2017, the Company’s Board of Directors authorized an expenditure of up to $2.5 billion for the repurchase of shares of the Company’s common stock through June 30, 2019. As of September 30, 2018, the Company had $944 million remaining under its share repurchase authorization.
The Company may also reacquire shares of its common stock under its share-based compensation plans related to restricted stock awards and certain option exercises. The holders of restricted shares may elect to surrender a portion of their shares on the vesting date to cover their income tax obligation. These vested restricted shares are reacquired by the Company and the Company’s payment of the holders’ income tax obligations are recorded as a treasury share purchase.
For the nine months ended September 30, 2018 and 2017, the Company reacquired 0.3 million shares and 0.3 million shares, respectively, of its common stock through the surrender of shares upon vesting and paid in the aggregate $43 million and $33 million, respectively, related to the holders’ income tax obligations on the vesting date. Option holders may elect to net settle their vested awards resulting in the surrender of the number of shares required to cover the strike price and tax obligation of the options exercised. These shares are reacquired by the Company and recorded as treasury shares. For the nine months ended September 30, 2018 and
2017, the Company reacquired 0.5 million shares and 1.9 million shares, respectively, of its common stock through the net settlement of options for an aggregate value of $82 million and $248 million, respectively.
During both the nine months ended September 30, 2018 and 2017, the Company reissued 0.8 million treasury shares for restricted stock award grants, performance share units and issuance of shares vested under advisor deferred compensation plans.